Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
CONTEXT: A past history of gestational diabetes mellitus (GDM) confers a very high risk of postpartum development of diabetes, particularly type 2 diabetes. OBJECTIVE: The Diabetes Prevention Program (DPP) sought to identify individuals with impaired glucose tolerance (IGT) and intervene in an effort to prevent or delay their progression to diabetes. This analysis examined the differences between women enrolled in DPP with and without a reported history of GDM. DESIGN: The DPP was a randomized, controlled clinical trial. SETTING: The study was a multicenter, National Institutes of Health-sponsored trial carried out at 27 centers including academic and Indian Health Services sites. PATIENTS: A total of 2190 women were randomized into the DPP and provided information for past history of GDM. This analysis addressed the differences between those 350 women providing a past history of GDM and those 1416 women with a previous live birth but no history of GDM. INTERVENTIONS: Subjects were randomized to either standard lifestyle and placebo or metformin therapy or to an intensive lifestyle intervention. MAIN OUTCOMES: The primary outcome was the time to development of diabetes ascertained by semiannual fasting plasma glucose and annual oral glucose tolerance testing. Assessments of insulin secretion and insulin sensitivity were also performed. RESULTS: Whereas entering the study with similar glucose levels, women with a history of GDM randomized to placebo had a crude incidence rate of diabetes 71% higher than that of women without such a history. Among women reporting a history of GDM, both intensive lifestyle and metformin therapy reduced the incidence of diabetes by approximately 50% compared with the placebo group, whereas this reduction was 49 and 14%, respectively in parous women without GDM. These data suggest that metformin may be more effective in women with a GDM history as compared with those without. CONCLUSIONS: Progression to diabetes is more common in women with a history of GDM compared with those without GDM history despite equivalent degrees of IGT at baseline. Both intensive lifestyle and metformin are highly effective in delaying or preventing diabetes in women with IGT and a history of GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Indian and US Diabetes Prevention studies, conducted in people with prior prediabetes or gestational diabetes mellitus (GDM) and likely to include many women with PCOS, reported that metformin lowered weight and BMI and reduced progression to DM2 (Knowler et al. , 2002; Ramachandran et al. , 2006), with metformin more effective for women with prior GDM (Ratner et al. , 2008).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Ratner et al. , 2008
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this respect, Ratner et al. showed that metformin and lifestyle interventions in women with the history of GDM could steadily decrease weight gain as well as reduce the future risk of obesity and overt diabetes [35].”
From Trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study (2019) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As effective prevention interventions are available (203,204), individuals diagnosed with GDM should receive lifelong screening for prediabetes to allow interventions to reduce diabetes risk and for type 2 diabetes to allow treatment at the earliest possible time (205).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [203]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When 350 women with previous GDM were randomized in the Diabetes Prevention Program trial, treatment with metformin or intensive lifestyle modification resulted in a 50% reduction in the annual development of type 2 diabetes mellitus.36”
From One-step or 2-step testing for gestational diabetes: which is better? (2021) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“Both metformin and intensive lifestyle intervention prevent or delay progression to diabetes in individuals with prediabetes and a history of GDM.”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [140]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
(1964) · PubMed · Cited by 1,230
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
O'Sullivan, J. B. (1991) · Diabetes · doi:10.2337/diab.40.2.s131 · Cited by 332
Research works printed but not linked: 1
- Holm, 1979, A simple sequentially rejective Bonferroni test procedure., Scan J Statistics, 6, 5
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“In the DPP, for women with a history of GDM, metformin and intensive lifestyle modification led to an equivalent 50% reduction in diabetes risk (61).”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“In women in the DPP with a history of GDM,metformin and intensive lifestyle modification led to an equivalent 50% reduction in the risk of diabetes (55).”
BackgroundType 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Parikh, N. I., Gonzalez, J. M., Anderson, C. A. M., Judd, S. E., Rexrode, K. M., Hlatky, M. A., Gunderson, E. P., Stuart, J. J., Vaidya, D., & On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. A. T. S. C. (2021) · Circulation · doi:10.1161/cir.0000000000000961 · Cited by 743
Gestational Diabetes Mellitus: Risks and Management during and after Pregnancy
Buchanan, T. A., Xiang, A. H., & Page, K. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.96 · Cited by 718
Sex differences in type 2 diabetes
Kautzky-Willer, A., Leutner, M., & Harreiter, J. (2023) · Diabetologia · doi:10.1007/s00125-023-05891-x · Cited by 624
“Although intervention strategies are an effective approach to reducing incident type 2 diabetes, in the Diabetes Prevention Program, the incidence of type 2 diabetes in women with prior GDM was still 70% higher over 3 years than in women with prediabetes or normoglycaemia in previous pregnancies [48].”
BackgroundDamm, P., Houshmand-Oeregaard, A., Kelstrup, L., Lauenborg, J., Mathiesen, E. R., & Clausen, T. D. (2016) · Diabetologia · doi:10.1007/s00125-016-3985-5 · Cited by 620
Gong, Q., Zhang, P., Wang, J., Ma, J., An, Y., Chen, Y., Zhang, B., Feng, X., Li, H., Chen, X., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30093-2 · Cited by 615
Self-citationThyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598
Gestational diabetes mellitus: an updated overview
Chiefari, E., Arcidiacono, B., Foti, D., & Brunetti, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0607-5 · Cited by 522
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Diagnosis and Management of Prediabetes: A Review
Echouffo-Tcheugui, J. B., Perreault, L., Ji, L., & Dagogo-Jack, S. (2023) · JAMA · doi:10.1001/jama.2023.4063 · Cited by 473
A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Paulweber, B., Valensi, P., Lindström, J., Lalic, N., Greaves, C., McKee, M., Kissimova-Skarbek, K., Liatis, S., Cosson, E., Szendroedi, J., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1240928 · Cited by 469
Aroda, V. R., Christophi, C. A., Edelstein, S. L., Zhang, P., Herman, W. H., Barrett-Connor, E., Delahanty, L. M., Montez, M. G., Ackermann, R. T., Zhuo, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3761 · Cited by 467
Self-citationPrediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
Maternal metabolism and obesity: modifiable determinants of pregnancy outcome
Nelson, S. M., Matthews, P., & Poston, L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp050 · Cited by 370
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Self-citationFeig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
“prevent/delay the onset of diabetes [Grade B, Level 2 (477,478)].”
BackgroundNaderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv025 · Cited by 334
13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s013 · Cited by 332
Daly, B., Toulis, K. A., Thomas, N., Gokhale, K., Martin, J., Webber, J., Keerthy, D., Jolly, K., Saravanan, P., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002488 · Cited by 328
Gestational diabetes mellitus: results from a survey of country prevalence and practices
Jiwani, A., Marseille, E., Lohse, N., Damm, P., Hod, M., & Kahn, J. G. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.587921 · Cited by 316
Rayanagoudar, G., Hashi, A. A., Zamora, J., Khan, K. S., Hitman, G. A., & Thangaratinam, S. (2016) · Diabetologia · doi:10.1007/s00125-016-3927-2 · Cited by 292
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Hostalek, U., Gwilt, M., & Hildemann, S. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278
Nielsen, K. K., Kapur, A., Damm, P., de Courten, M., & Bygbjerg, I. C. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-41 · Cited by 275
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
Risk factors for gestational diabetes: is prevention possible?
Zhang, C., Rawal, S., & Chong, Y. S. (2016) · Diabetologia · doi:10.1007/s00125-016-3979-3 · Cited by 267
14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s014 · Cited by 265
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv063 · Cited by 255
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
Lewey, J., Beckie, T. M., Brown, H. L., Brown, S. D., Garovic, V. D., Khan, S. S., Miller, E. C., Sharma, G., Mehta, L. S., & on behalf of the American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, C. C. (2024) · Circulation · doi:10.1161/cir.0000000000001212 · Cited by 229
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
Effect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study
Simmons, D., Devlieger, R., van Assche, A., Jans, G., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Desoye, G., Harreiter, J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3455 · Cited by 225
Tobias, D. K., Hu, F. B., Chavarro, J., Rosner, B., Mozaffarian, D., & Zhang, C. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.3747 · Cited by 219
Dennison, R. A., Chen, E. S., Green, M. E., Legard, C., Kotecha, D., Farmer, G., Sharp, S. J., Ward, R. J., Usher-Smith, J. A., & Griffin, S. J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108625 · Cited by 214
Diet and exercise interventions for preventing gestational diabetes mellitus
Bain, E., Crane, M., Tieu, J., Han, S., Crowther, C. A., & Middleton, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010443.pub2 · Cited by 188
Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
Pathophysiology from preconception, during pregnancy, and beyond.
Hivert, M.-F., Backman, H., Benhalima, K., Catalano, P., Desoye, G., Immanuel, J., McKinlay, C. J. D., Meek, C. L., Nolan, C. J., Ram, U., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00827-4 · Cited by 186
Nicklas, J. M., Zera, C. A., Seely, E. W., Abdul-Rahim, Z. S., Rudloff, N. D., & Levkoff, S. E. (2011) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-11-23 · Cited by 177
“Prevention Program demonstrated that an intensive behavioral lifestyle intervention to prevent type 2 diabetes was equally effective among women with and without self-reported prior history of GDM [9].”
BackgroundMethodFerrara, A., Hedderson, M. M., Brown, S. D., Albright, C. L., Ehrlich, S. F., Tsai, A.-L., Caan, B. J., Sternfeld, B., Gordon, N. P., Schmittdiel, J. A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1254 · Cited by 171
Bao, W., Tobias, D. K., Bowers, K., Chavarro, J., Vaag, A., Grunnet, L. G., Strøm, M., Mills, J., Liu, A., Kiely, M., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1795 · Cited by 166
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s003 · Cited by 162
Nicklas, J. M., Zera, C. A., England, L. J., Rosner, B. A., Horton, E., Levkoff, S. E., & Seely, E. W. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000420 · Cited by 140
“(11) Since women with GDM tend to retain or gain weight postpartum (9), we believe our findings demonstrating a 3.”
BackgroundMetabolic diseases and associated complications: sex and gender matter
Kautzky‐Willer, A., & Handisurya, A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02161.x · Cited by 138
Bao, W., Yeung, E., Tobias, D. K., Hu, F. B., Vaag, A. A., Chavarro, J. E., Mills, J. L., Grunnet, L. G., Bowers, K., Ley, S. H., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3537-4 · Cited by 137
“A subgroup analysis of the Diabetes Prevention Program (DPP) randomised clinical trial showed that intensive lifestyle intervention including diet, physical activity and weight loss reduced the incidence of type 2 diabetes over 3 years among women with impaired glucose tolerance and a history of GDM [32].”
BackgroundDiabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1970 · Cited by 128
Self-citationAssociation between healthy maternal dietary pattern and risk for gestational diabetes mellitus
Tryggvadottir, E. A., Medek, H., Birgisdottir, B. E., Geirsson, R. T., & Gunnarsdottir, I. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.145 · Cited by 119
Handley, M. A., Harleman, E., Gonzalez-Mendez, E., Stotland, N. E., Althavale, P., Fisher, L., Martinez, D., Ko, J., Sausjord, I., & Rios, C. (2015) · Implementation Science · doi:10.1186/s13012-016-0426-2 · Cited by 116
Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus
Moon, J. H., Kwak, S. H., & Jang, H. C. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.203 · Cited by 93
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90
Pérez-Ferre, N., Del Valle, L., Torrejón, M. J., Barca, I., Calvo, M. I., Matía, P., Rubio, M. A., & Calle-Pascual, A. L. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.09.005 · Cited by 87
Durnwald, C. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.05.002 · Cited by 85
Jang, H. C. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.1.1 · Cited by 78
Metformin and Type 2 Diabetes Prevention
Aroda, V. R., & Ratner, R. E. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0020 · Cited by 70
“Namely, metformin was comparable to intensive lifestyle intervention in obese individuals with a BMI ≥35 kg/m2, demonstrating a 53% reduction in progression to diabetes (compared to 51% for lifestyle); in younger individuals aged 25–44 years, with a 44% reduction compared to 48% with lifestyle (3); and in women with a…”
BackgroundSelf-citationNasiri-Amiri, F., Sepidarkish, M., Shirvani, M. A., Habibipour, P., & Tabari, N. S. M. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0470-6 · Cited by 67
Noctor, E., Crowe, C., Carmody, L. A., Saunders, J. A., Kirwan, B., O’Dea, A., Gillespie, P., Glynn, L. G., McGuire, B. E., O’Neill, C., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1260 · Cited by 65
Peacock, A. S., Bogossian, F. E., Wilkinson, S. A., Gibbons, K. S., Kim, C., & McIntyre, H. D. (2015) · International Journal of Endocrinology · doi:10.1155/2015/423717 · Cited by 59
Moon, J. H., Kwak, S. H., Jung, H. S., Choi, S. H., Lim, S., Cho, Y. M., Park, K. S., Jang, H. C., & Cho, N. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1113 · Cited by 58
Kwak, S. H., Choi, S. H., Kim, K., Jung, H. S., Cho, Y. M., Lim, S., Cho, N. H., Kim, S. Y., Park, K. S., & Jang, H. C. (2013) · Diabetologia · doi:10.1007/s00125-013-3059-x · Cited by 56
Juan, J., Sun, Y., Wei, Y., Wang, S., Song, G., Yan, J., Zhou, P., & Yang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1012244 · Cited by 56
Werner, E. F., Has, P., Rouse, D., & Clark, M. A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.05.036 · Cited by 52
Girgis, C. M., Gunton, J. E., & Cheung, N. W. (2012) · ISRN Endocrinology · doi:10.5402/2012/341638 · Cited by 50
Cheung, N. W., Blumenthal, C., Smith, B. J., Hogan, R., Thiagalingam, A., Redfern, J., Barry, T., Cinnadaio, N., & Chow, C. K. (2019) · Nutrients · doi:10.3390/nu11030590 · Cited by 47
“These interventions have been shown to be effective in the subgroup of women with IGT who have had a history of prior GDM [12].”
BackgroundGlucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria
Benhalima, K., Jegers, K., Devlieger, R., Verhaeghe, J., & Mathieu, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157272 · Cited by 45
One-step or 2-step testing for gestational diabetes: which is better?
Coustan, D. R., Dyer, A. R., & Metzger, B. E. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.05.009 · Cited by 40
Self-citationWindows of Opportunity for Lifestyle Interventions to Prevent Gestational Diabetes Mellitus
Phelan, S. (2016) · American Journal of Perinatology · doi:10.1055/s-0036-1586504 · Cited by 38
Bennett, W. L., Liu, S.-H., Yeh, H.-C., Nicholson, W. K., Gunderson, E. P., Lewis, C. E., & Clark, J. M. (2013) · Obesity · doi:10.1002/oby.20133 · Cited by 38
Knowler, W. C., Doherty, L., Edelstein, S. L., Bennett, P. H., Dabelea, D., Hoskin, M., Kahn, S. E., Kalyani, R. R., Kim, C., Pi-Sunyer, F. X., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00022-1 · Cited by 39
Self-citationWhat Is Gestational Diabetes—Really?
Buchanan, T. A., Xiang, A. H., Page, K. A., & Watanabe, R. M. (2025) · Diabetes · doi:10.2337/dbi24-0041 · Cited by 31
Pathirana, M. M., Ali, A., Lassi, Z. S., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2022) · Journal of Human Lactation · doi:10.1177/08903344211034779 · Cited by 29
The Effectiveness of Metformin in Diabetes Prevention: A Systematic Review and Meta-Analysis
Patel, D., Ayesha, I. E., Monson, N. R., Klair, N., Patel, U., Saxena, A., & Hamid, P. (2023) · Cureus · doi:10.7759/cureus.46108 · Cited by 29
Towards a global consensus on GDM diagnosis: Light at the end of the tunnel?
Kapur, A., McIntyre, H. D., Divakar, H., Di Renzo, G. C., Kihara, A. B., McAuliffe, F., Hanson, M., Ma, R. C., Hod, M., & FIGO Working Group on Hyperglycemia in Pregnancy (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13149 · Cited by 22
Bracco, P. A., Reichelt, A. J., Alves, L. F., Vidor, P. R., Oppermann, M. L. R., Duncan, B. B., & Schmidt, M. I. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01606-x · Cited by 18
Oh, T. J., Kim, Y. G., Kang, S., Moon, J. H., Kwak, S. H., Choi, S. H., Lim, S., Park, K. S., Jang, H. C., Hong, J.-S., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0086 · Cited by 17
Behboudi-Gandevani, S., Ramezani Tehrani, F., Rahmati, M., Amiri, M., & Azizi, F. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0348-5 · Cited by 14
Petroni, M. L., Brodosi, L., Armandi, A., Marchignoli, F., Bugianesi, E., & Marchesini, G. (2023) · Nutrients · doi:10.3390/nu15030792 · Cited by 12
Tsushima, R., Ito, A., Oishi, M., Ishihara, K., Iino, K., Tanaka, K., & Yokoyama, Y. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15072634
Metadata
- Authors
- Ratner, R. E., Christophi, C. A., Metzger, B. E., Dabelea, D., Bennett, P. H., Pi-Sunyer, X., Fowler, S., Kahn, S. E., & The Diabetes Prevention Program Research Group
- Affiliations
- MedStar Health Research Institute (US)
- George Washington University (US)
- University of Colorado Denver (US)
- National Institutes of Health (US)
- University of Washington (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-12-01
- Volume
- 93
- Issue
- 12
- Pages
- 4774-4779
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2626441
- OpenAlex
- W2166996912
- Semantic Scholar
- 34d9e25b6e8d5b51f66be774a60ed5bf5dbe8db3
- Cited by
- 867
- References
- 14
- Citations by year
- 2026: 35 · 2025: 38 · 2024: 52 · 2023: 55 · 2022: 52 · 2021: 62 · 2020: 68 · 2019: 45 · 2018: 53 · 2017: 49 · 2016: 52 · 2015: 61 · 2014: 74 · 2013: 38 · 2012: 49
- FWCI
- 30.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- gestational diabetes mellitus, type 2 diabetes prevention, metformin, intensive lifestyle intervention, impaired glucose tolerance, Diabetes Prevention Program, insulin secretion, insulin sensitivity, diabetes incidence
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Double-Blind Method, Female, Humans, Hypoglycemic Agents, Life Style, Metformin, Motor Activity, Pregnancy, Risk Factors, Proportional Hazards Models, Diabetes, Gestational, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.